rs1555568475

Variant summary

Our verdict is Pathogenic.
+14 Pathogenic
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 14 classification points (ACMG Germline Pathogenicity v2019). PVS1PM2PP5_Strong

The NM_000304.4(PMP22):c.83G>A (p.Trp28*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant is predicted to lead to nonsense-mediated mRNA decay (NMD). The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. In-silico predictor (BayesDel (noAF)) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★).

Frequency

Genomes: not found (cov: 31)

Consequence

PMP22
NM_000304.4 stop_gained

Scores

5
2

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:2

Conservation

PhyloP100: 4.12

Publications

1 publications found
Variant links:
Genes affected
PMP22 (HGNC:9118): (peripheral myelin protein 22) This gene encodes an integral membrane protein that is a major component of myelin in the peripheral nervous system. Studies suggest two alternately used promoters drive tissue-specific expression. Various mutations of this gene are causes of Charcot-Marie-Tooth disease Type IA, Dejerine-Sottas syndrome, and hereditary neuropathy with liability to pressure palsies. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
PMP22 Gene-Disease associations (from GenCC):
  • Charcot-Marie-Tooth disease type 1A
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, ClinGen, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • hereditary neuropathy with liability to pressure palsies
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia, ClinGen, Orphanet
  • Charcot-Marie-Tooth disease type 1E
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • Charcot-Marie-Tooth disease type 3
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000304.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Pathogenic. The variant received 14 points.

PVS1Null variant in LOF gene
Frameshift/stop-gained, NMD predicted, LoF disease mechanism — very strong (PVS1); Stop-gained (exon 3 of 5) at amino acid 28 of 160, predicted to trigger nonsense-mediated mRNA decay. Loss of function is a known disease mechanism for this gene.
PM2Absent/extremely low in population databases
Absent from gnomAD (AD/XL gene) — PM2; Absent from gnomAD at well-covered site (MOI: AD+AR) (threshold 0.0001) — PM2 moderate.
PP5Reputable source reports pathogenic
ClinVar 2-star pathogenic — strong (PP5); ClinVar germline classification: Pathogenic/Likely Pathogenic, 2 star(s).

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000304.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PMP22
NM_000304.4
MANE Select
c.83G>Ap.Trp28*
stop_gained
Exon 3 of 5NP_000295.1Q01453
PMP22
NM_001281455.2
c.83G>Ap.Trp28*
stop_gained
Exon 3 of 5NP_001268384.1Q6FH25
PMP22
NM_001281456.2
c.83G>Ap.Trp28*
stop_gained
Exon 3 of 5NP_001268385.1Q01453

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PMP22
ENST00000312280.9
TSL:1 MANE Select
c.83G>Ap.Trp28*
stop_gained
Exon 3 of 5ENSP00000308937.3Q01453
PMP22
ENST00000395938.7
TSL:1
c.83G>Ap.Trp28*
stop_gained
Exon 3 of 5ENSP00000379269.3A0A6Q8PF08
PMP22
ENST00000494511.7
TSL:1
c.-27+5965G>A
intron
N/AENSP00000462782.2J3KT36

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 3 sources
GnomAD3 genomes
Cov:31
GnomAD4 exome
Cov:30
GnomAD4 genome
Cov:31
Showing 3 sources

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
1
-
-
Charcot-Marie-Tooth disease, type I (1)
1
-
-
Hereditary liability to pressure palsies (1)

Computational Scores

AlphaGenome AVI
Pathogenic49
BayesDel_addAF
Pathogenic0.63D
BayesDel_noAF
Pathogenic0.59
CADD
Pathogenic42
DANN
Uncertain1.0
Eigen
Pathogenic0.81
Eigen_PC
Pathogenic0.67
FATHMM_MKL
Uncertain0.89D
GPN-Star LLR
N/A-9.9
GPN-Star score
N/A9.9
Mutation Taster
N/A4/196disease causing (ClinVar)
PhyloP100
Uncertain4.1
RBP_binding_hub_radar
N/A0.0
RBP_regulation_power_radar
N/A1.7
Showing 14 of 14 scores

Splicing Scores

Pangolin (max)
Benign0.090
SpliceAI score (max)
Benign0.16
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.